Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| BeOne Medicines Ltd.ONC · Entity 2168 | President and COO | August 25, 2026 | August 27, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
BeOne Medicines Ltd.
Report date August 25, 2026 · Filed August 27, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| American Depositary SharesSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2026-08-25 transaction · row 4
Holding and transaction disclosures are not merged.
1 source rowRow 4 · 2026-08-25 · Sale · Disposed 280 · Balance 0 F1: Each American Depositary Share represents 13 Ordinary Shares. F2: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 7, 2025. |
| American Depositary SharesSEC Table I · non-derivative | Direct | 12,365 |
Reported balance
Holding disclosure · report date 2026-08-25 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 12,365 F1: Each American Depositary Share represents 13 Ordinary Shares. |
| Ordinary SharesSEC Table I · non-derivative | Direct | 1,270,084 |
Reported balance
Holding disclosure · report date 2026-08-25 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 1,270,084 |
| American Depositary SharesSEC Table I · non-derivative | IndirectBy Wife | 4,000 |
Reported balance
Holding disclosure · report date 2026-08-25 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 4,000 F1: Each American Depositary Share represents 13 Ordinary Shares. |
Filing footnotes · ownership attribution and instrument terms
F1: Each American Depositary Share represents 13 Ordinary Shares.
F2: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 7, 2025.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 06, 2021 Filed Jul 8, 2021 22:25 UTC | BeOne Medicines Ltd. BGNE · Entity 2168 | SaleAmerican Depositary Shares | 2,610 | $327.26 | $854,156.17 |
DisclosureSEC source: 0001651308-21-000149 · wf-form4_162578307197535.xml · nonDerivative · entry 8 Wu Xiaobin · CIK 0001739452 · President, COO & GM China 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,200 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 7, 2020. F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $326.81 to $327.76, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. Read SEC document |
| July 06, 2021 Filed Jul 8, 2021 22:25 UTC | BeOne Medicines Ltd. BGNE · Entity 2168 | SaleAmerican Depositary Shares | 2,114 | $326.30 | $689,804.33 |
DisclosureSEC source: 0001651308-21-000149 · wf-form4_162578307197535.xml · nonDerivative · entry 7 Wu Xiaobin · CIK 0001739452 · President, COO & GM China 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,810 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 7, 2020. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $325.81 to $326.78, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. Read SEC document |
| July 06, 2021 Filed Jul 8, 2021 22:25 UTC | BeOne Medicines Ltd. BGNE · Entity 2168 | SaleAmerican Depositary Shares | 1,600 | $323.76 | $518,018.40 |
DisclosureSEC source: 0001651308-21-000149 · wf-form4_162578307197535.xml · nonDerivative · entry 6 Wu Xiaobin · CIK 0001739452 · President, COO & GM China 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,924 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 7, 2020. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $323.55 to $324.33, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. Read SEC document |
| July 06, 2021 Filed Jul 8, 2021 22:25 UTC | BeOne Medicines Ltd. BGNE · Entity 2168 | SaleAmerican Depositary Shares | 2,256 | $323.15 | $729,024.82 |
DisclosureSEC source: 0001651308-21-000149 · wf-form4_162578307197535.xml · nonDerivative · entry 5 Wu Xiaobin · CIK 0001739452 · President, COO & GM China 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,524 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 7, 2020. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $322.54 to $323.51, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. Read SEC document |
| July 06, 2021 Filed Jul 8, 2021 22:25 UTC | BeOne Medicines Ltd. BGNE · Entity 2168 | SaleAmerican Depositary Shares | 400 | $321.46 | $128,584.96 |
DisclosureSEC source: 0001651308-21-000149 · wf-form4_162578307197535.xml · nonDerivative · entry 4 Wu Xiaobin · CIK 0001739452 · President, COO & GM China 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,780 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 7, 2020. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $321.19 to $321.65, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depository Shares sold at each separate price. Read SEC document |
| June 18, 2021 Filed Jun 21, 2021 20:49 UTC | BeOne Medicines Ltd. BGNE · Entity 2168 | SaleAmerican Depositary Shares | 1,156 | $330.93 | $382,550.57 |
DisclosureSEC source: 0001651308-21-000128 · wf-form4_162430851498091.xml · nonDerivative · entry 4 Wu Xiaobin · CIK 0001739452 · President, COO & GM China 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F2 · security: Each American Depositary Share represents 13 Ordinary Shares. F3 · kind: The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/4th of the securities will vest on each anniversary of June 17, 2020, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events following a change in control. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $330.9148 to $331.045, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depository Shares sold at each separate price. Read SEC document |
| June 16, 2021 Filed Jun 21, 2021 20:49 UTC | BeOne Medicines Ltd. BGNE · Entity 2168 | GrantShare Option (Right to Buy) · Derivative | 483,678 | $0.00 Strike: $26.53 | $0.00 |
DisclosureSEC source: 0001651308-21-000128 · wf-form4_162430851498091.xml · derivative · entry 5 Wu Xiaobin · CIK 0001739452 · President, COO & GM China 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 483,678 Underlying: Ordinary Shares · 483,678 shares Expires 2031-06-15 F5 · derivative.exercise_price: The number of securities underlying the option and the exercise price therefor are represented in ordinary shares. F5 · shares: The number of securities underlying the option and the exercise price therefor are represented in ordinary shares. F6 · derivative.exercise_date: These securities vest over a four-year period as follows: 25% on June 16, 2022, and the remaining in 36 successive equal monthly installments, subject to continued service. Unvested shares are subject toaccelerated vesting upon certain termination events following a change in control. Read SEC document |
| June 16, 2021 Filed Jun 21, 2021 20:49 UTC | BeOne Medicines Ltd. BGNE · Entity 2168 | GrantOrdinary Shares | 78,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001651308-21-000128 · wf-form4_162430851498091.xml · nonDerivative · entry 1 Wu Xiaobin · CIK 0001739452 · President, COO & GM China 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,213,729 F1 · security: Represents securities underlying restricted share units. 1/4th of the securities will vest on each anniversary of June 16, 2021, subject to continued service. Unvested securities are subject to accelerated vestingupon certain termination events following a change in control. Read SEC document |
| June 07, 2021 Filed Jun 9, 2021 20:49 UTC | BeOne Medicines Ltd. BGNE · Entity 2168 | SaleAmerican Depositary Shares | 2 | $351.53 | $703.05 |
DisclosureSEC source: 0001651308-21-000110 · wf-form4_162327176662694.xml · nonDerivative · entry 6 Wu Xiaobin · CIK 0001739452 · President, COO & GM China 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/4th of the securities will vest on each anniversary of June 5, 2019, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events following a change in control. Read SEC document |
| June 07, 2021 Filed Jun 9, 2021 20:49 UTC | BeOne Medicines Ltd. BGNE · Entity 2168 | SaleAmerican Depositary Shares | 571 | $353.57 | $201,888.13 |
DisclosureSEC source: 0001651308-21-000110 · wf-form4_162327176662694.xml · nonDerivative · entry 5 Wu Xiaobin · CIK 0001739452 · President, COO & GM China 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/4th of the securities will vest on each anniversary of June 5, 2019, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events following a change in control. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $353.37 to $353.82, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. Read SEC document |
| June 07, 2021 Filed Jun 9, 2021 20:49 UTC | BeOne Medicines Ltd. BGNE · Entity 2168 | SaleAmerican Depositary Shares | 2,825 | $352.33 | $995,326.04 |
DisclosureSEC source: 0001651308-21-000110 · wf-form4_162327176662694.xml · nonDerivative · entry 4 Wu Xiaobin · CIK 0001739452 · President, COO & GM China 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 573 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/4th of the securities will vest on each anniversary of June 5, 2019, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events following a change in control. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $352.1054 to $352.90, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depository Shares sold at each separate price. Read SEC document |
| May 03, 2021 Filed May 5, 2021 20:46 UTC | BeOne Medicines Ltd. BGNE · Entity 2168 | SaleAmerican Depositary Shares | 6,715 | $343.00 | $2,303,245.00 |
DisclosureSEC source: 0001651308-21-000080 · wf-form4_162024759149920.xml · nonDerivative · entry 4 Wu Xiaobin · CIK 0001739452 · President, COO & GM China 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F2 · security: Each American Depositary Share represents 13 Ordinary Shares. F3 · kind: The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person on April 30, 2018. 1/5th of the securities will vest on each anniversary of April 30, 2018, subject to continued service. Unvested securities are subject to accelerated vesting upon a change in control or certain termination events. Read SEC document |
| October 05, 2020 Filed Oct 7, 2020 20:52 UTC | BeOne Medicines Ltd. BGNE · Entity 2168 | SaleAmerican Depositary Shares | 4,000 | $300.00 | $1,200,000.00 |
DisclosureSEC source: 0001651308-20-000195 · wf-form4_160210393199257.xml · nonDerivative · entry 4 Wu Xiaobin · CIK 0001739452 · President & GM China 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 11, 2020. Read SEC document |
| September 25, 2020 Filed Sep 29, 2020 20:57 UTC | BeOne Medicines Ltd. BGNE · Entity 2168 | SaleAmerican Depositary Shares | 4,000 | $280.35 | $1,121,406.00 |
DisclosureSEC source: 0001651308-20-000175 · wf-form4_160141305130914.xml · nonDerivative · entry 4 Wu Xiaobin · CIK 0001739452 · President & GM China 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 11, 2020. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $280.00 to $280.95, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. Read SEC document |
| September 17, 2020 Filed Sep 21, 2020 20:50 UTC | BeOne Medicines Ltd. BGNE · Entity 2168 | SaleAmerican Depositary Shares | 500 | $261.23 | $130,615.00 |
DisclosureSEC source: 0001651308-20-000161 · wf-form4_160072143364880.xml · nonDerivative · entry 5 Wu Xiaobin · CIK 0001739452 · President & GM China 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F2 · security: Each American Depositary Share represents 13 Ordinary Shares. F3 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 11, 2020. Read SEC document |
| September 17, 2020 Filed Sep 21, 2020 20:50 UTC | BeOne Medicines Ltd. BGNE · Entity 2168 | SaleAmerican Depositary Shares | 3,500 | $260.20 | $910,711.90 |
DisclosureSEC source: 0001651308-20-000161 · wf-form4_160072143364880.xml · nonDerivative · entry 4 Wu Xiaobin · CIK 0001739452 · President & GM China 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 500 F2 · security: Each American Depositary Share represents 13 Ordinary Shares. F3 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 11, 2020. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $260.00 to $260.72, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. Read SEC document |
| July 20, 2020 Filed Jul 21, 2020 20:50 UTC | BeOne Medicines Ltd. BGNE · Entity 2168 | SaleAmerican Depositary Shares | 2,600 | $250.16 | $650,407.42 |
DisclosureSEC source: 0001651308-20-000102 · wf-form4_159536460705456.xml · nonDerivative · entry 6 Wu Xiaobin · CIK 0001739452 · President & GM China 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 5, 2019. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $250.00 to $250.43, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. Read SEC document |
| July 17, 2020 Filed Jul 21, 2020 20:50 UTC | BeOne Medicines Ltd. BGNE · Entity 2168 | SaleAmerican Depositary Shares | 400 | $250.04 | $100,015.00 |
DisclosureSEC source: 0001651308-20-000102 · wf-form4_159536460705456.xml · nonDerivative · entry 5 Wu Xiaobin · CIK 0001739452 · President & GM China 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 5, 2019. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $250.00 to $250.12, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. Read SEC document |
| July 17, 2020 Filed Jul 21, 2020 20:50 UTC | BeOne Medicines Ltd. BGNE · Entity 2168 | SaleAmerican Depositary Shares | 300 | $240.00 | $72,000.00 |
DisclosureSEC source: 0001651308-20-000102 · wf-form4_159536460705456.xml · nonDerivative · entry 4 Wu Xiaobin · CIK 0001739452 · President & GM China 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 400 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 5, 2019. Read SEC document |
| July 15, 2020 Filed Jul 15, 2020 21:14 UTC | BeOne Medicines Ltd. BGNE · Entity 2168 | SaleAmerican Depositary Shares | 200 | $246.10 | $49,220.00 |
DisclosureSEC source: 0001651308-20-000098 · wf-form4_159484765431414.xml · nonDerivative · entry 8 Wu Xiaobin · CIK 0001739452 · President & GM China 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 5, 2019. Read SEC document |
| July 15, 2020 Filed Jul 15, 2020 21:14 UTC | BeOne Medicines Ltd. BGNE · Entity 2168 | SaleAmerican Depositary Shares | 200 | $243.91 | $48,781.00 |
DisclosureSEC source: 0001651308-20-000098 · wf-form4_159484765431414.xml · nonDerivative · entry 7 Wu Xiaobin · CIK 0001739452 · President & GM China 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 5, 2019. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $243.75 to $244.06, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. Read SEC document |
| July 15, 2020 Filed Jul 15, 2020 21:14 UTC | BeOne Medicines Ltd. BGNE · Entity 2168 | SaleAmerican Depositary Shares | 300 | $242.63 | $72,789.00 |
DisclosureSEC source: 0001651308-20-000098 · wf-form4_159484765431414.xml · nonDerivative · entry 6 Wu Xiaobin · CIK 0001739452 · President & GM China 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 400 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 5, 2019. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $242.43 to $243.01, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. Read SEC document |
| July 15, 2020 Filed Jul 15, 2020 21:14 UTC | BeOne Medicines Ltd. BGNE · Entity 2168 | SaleAmerican Depositary Shares | 2,000 | $240.10 | $480,207.60 |
DisclosureSEC source: 0001651308-20-000098 · wf-form4_159484765431414.xml · nonDerivative · entry 5 Wu Xiaobin · CIK 0001739452 · President & GM China 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 700 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 5, 2019. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $240.00 to $240.56, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. Read SEC document |
| July 13, 2020 Filed Jul 15, 2020 21:14 UTC | BeOne Medicines Ltd. BGNE · Entity 2168 | SaleAmerican Depositary Shares | 3,000 | $220.00 | $660,000.00 |
DisclosureSEC source: 0001651308-20-000098 · wf-form4_159484765431414.xml · nonDerivative · entry 4 Wu Xiaobin · CIK 0001739452 · President & GM China 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 5, 2019. Read SEC document |
| June 17, 2020 Filed Jun 19, 2020 20:09 UTC | BeOne Medicines Ltd. BGNE · Entity 2168 | GrantShare Option (Right to Buy) · Derivative | 756,821 | $0.00 Strike: $13.42 | $0.00 |
DisclosureSEC source: 0001651308-20-000074 · wf-form4_159259735674939.xml · derivative · entry 4 Wu Xiaobin · CIK 0001739452 · President & GM China 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 756,821 Underlying: Ordinary Shares · 756,821 shares Expires 2030-06-16 F3 · derivative.exercise_price: The number of securities underlying each option and the exercise price therefor are represented in ordinary shares. F3 · shares: The number of securities underlying each option and the exercise price therefor are represented in ordinary shares. F4 · derivative.exercise_date: These securities vest over a four-year period as follows: 25% on June 17, 2021 with the remaining shares vesting in 36 equal successive monthly installments thereafter, subject to continued service. Unvested shares are subject to accelerated vesting upon certain termination events following a change in control. F3 · derivative.underlying_shares: The number of securities underlying each option and the exercise price therefor are represented in ordinary shares. F3 · balance_after: The number of securities underlying each option and the exercise price therefor are represented in ordinary shares. Read SEC document |
| June 17, 2020 Filed Jun 19, 2020 20:09 UTC | BeOne Medicines Ltd. BGNE · Entity 2168 | GrantOrdinary Shares | 134,147 | $0.00 | $0.00 |
DisclosureSEC source: 0001651308-20-000074 · wf-form4_159259735674939.xml · nonDerivative · entry 1 Wu Xiaobin · CIK 0001739452 · President & GM China 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,514,562 F1 · security: Represents securities underlying restricted share units. 1/4th of the securities will vest on each anniversary of June 17, 2020, subject to continued service. Unvested shares are subject to accelerated vesting upon certain termination events following a change in control. Read SEC document |
| June 08, 2020 Filed Jun 10, 2020 21:15 UTC | BeOne Medicines Ltd. BGNE · Entity 2168 | SaleAmerican Depositary Shares | 475 | $171.98 | $81,690.55 |
DisclosureSEC source: 0001651308-20-000066 · wf-form4_159182370219716.xml · nonDerivative · entry 6 Wu Xiaobin · CIK 0001739452 · President & GM China 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/4th of the securities will vest on each anniversary of June 5, 2019, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events following a change in control. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $171.73 to $172.46, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depository Shares sold at each separate price. Read SEC document |
| June 08, 2020 Filed Jun 10, 2020 21:15 UTC | BeOne Medicines Ltd. BGNE · Entity 2168 | SaleAmerican Depositary Shares | 1,125 | $171.20 | $192,604.84 |
DisclosureSEC source: 0001651308-20-000066 · wf-form4_159182370219716.xml · nonDerivative · entry 5 Wu Xiaobin · CIK 0001739452 · President & GM China 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 475 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/4th of the securities will vest on each anniversary of June 5, 2019, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events following a change in control. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $170.5438 to $171.44, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. Read SEC document |
| June 08, 2020 Filed Jun 10, 2020 21:15 UTC | BeOne Medicines Ltd. BGNE · Entity 2168 | SaleAmerican Depositary Shares | 1,200 | $170.02 | $204,022.08 |
DisclosureSEC source: 0001651308-20-000066 · wf-form4_159182370219716.xml · nonDerivative · entry 4 Wu Xiaobin · CIK 0001739452 · President & GM China 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,600 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/4th of the securities will vest on each anniversary of June 5, 2019, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events following a change in control. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $169.52 to $170.24, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depository Shares sold at each separate price. Read SEC document |
| May 01, 2020 Filed May 5, 2020 20:46 UTC | BeOne Medicines Ltd. BGNE · Entity 2168 | SaleAmerican Depositary Shares | 245 | $141.00 | $34,545.00 |
DisclosureSEC source: 0001651308-20-000045 · wf-form4_158871159383308.xml · nonDerivative · entry 7 Wu Xiaobin · CIK 0001739452 · President & GM China 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F2 · security: Each American Depositary Share represents 13 Ordinary Shares. F4 · kind: The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person on April 30, 2018. 1/5th of the securities will vest on each anniversary of April 30, 2018, subject to continued service. Unvested securities are subject to accelerated vesting upon a change in control or certain termination events. Read SEC document |
| May 01, 2020 Filed May 5, 2020 20:46 UTC | BeOne Medicines Ltd. BGNE · Entity 2168 | SaleAmerican Depositary Shares | 300 | $143.17 | $42,951.99 |
DisclosureSEC source: 0001651308-20-000045 · wf-form4_158871159383308.xml · nonDerivative · entry 6 Wu Xiaobin · CIK 0001739452 · President & GM China 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 245 F2 · security: Each American Depositary Share represents 13 Ordinary Shares. F4 · kind: The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person on April 30, 2018. 1/5th of the securities will vest on each anniversary of April 30, 2018, subject to continued service. Unvested securities are subject to accelerated vesting upon a change in control or certain termination events. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $143.00 to $143.37, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. Read SEC document |
| May 01, 2020 Filed May 5, 2020 20:46 UTC | BeOne Medicines Ltd. BGNE · Entity 2168 | SaleAmerican Depositary Shares | 1,224 | $142.54 | $174,469.20 |
DisclosureSEC source: 0001651308-20-000045 · wf-form4_158871159383308.xml · nonDerivative · entry 5 Wu Xiaobin · CIK 0001739452 · President & GM China 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 545 F2 · security: Each American Depositary Share represents 13 Ordinary Shares. F4 · kind: The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person on April 30, 2018. 1/5th of the securities will vest on each anniversary of April 30, 2018, subject to continued service. Unvested securities are subject to accelerated vesting upon a change in control or certain termination events. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $142.00 to $142.97, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. Read SEC document |
| May 01, 2020 Filed May 5, 2020 20:46 UTC | BeOne Medicines Ltd. BGNE · Entity 2168 | SaleAmerican Depositary Shares | 5,255 | $140.96 | $740,744.80 |
DisclosureSEC source: 0001651308-20-000045 · wf-form4_158871159383308.xml · nonDerivative · entry 4 Wu Xiaobin · CIK 0001739452 · President & GM China 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,769 F2 · security: Each American Depositary Share represents 13 Ordinary Shares. F4 · kind: The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person on April 30, 2018. 1/5th of the securities will vest on each anniversary of April 30, 2018, subject to continued service. Unvested securities are subject to accelerated vesting upon a change in control or certain termination events. Read SEC document |
| November 15, 2019 Filed Nov 18, 2019 22:22 UTC | BeOne Medicines Ltd. BGNE · Entity 2168 | SaleAmerican Depositary Shares | 1,000 | $202.05 | $202,050.00 |
DisclosureSEC source: 0001651308-19-000116 · wf-form4_157411574054527.xml · nonDerivative · entry 3 Wu Xiaobin · CIK 0001739452 · President & GM China 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 5, 2018. Read SEC document |
| November 01, 2019 Filed Nov 5, 2019 21:20 UTC | BeOne Medicines Ltd. BGNE · Entity 2168 | SaleAmerican Depositary Shares | 1,000 | $180.00 | $180,000.00 |
DisclosureSEC source: 0001651308-19-000102 · wf-form4_157298880433664.xml · nonDerivative · entry 3 Wu Xiaobin · CIK 0001739452 · President & GM China 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. Read SEC document |
| June 05, 2019 Filed Jun 7, 2019 20:13 UTC | BeOne Medicines Ltd. BGNE · Entity 2168 | GrantShare Option (Right to Buy) · Derivative | 797,550 | $0.00 Strike: $9.23 | $0.00 |
DisclosureSEC source: 0001651308-19-000057 · wf-form4_155993838897104.xml · derivative · entry 3 Wu Xiaobin · CIK 0001739452 · President & GM China 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 797,550 Underlying: Ordinary Shares · 797,550 shares Expires 2029-06-04 F3 · derivative.exercise_price: The number of securities underlying each option and the exercise price therefore are represented in ordinary shares. F3 · shares: The number of securities underlying each option and the exercise price therefore are represented in ordinary shares. F4 · derivative.exercise_date: These securities vest over a four-year period as follows: 25% on June 5, 2020, and the remaining in 36 successive equal monthly installments, subject to continued service. Unvested shares are subject to accelerated vesting upon certain termination events following a change in control. F3 · derivative.underlying_shares: The number of securities underlying each option and the exercise price therefore are represented in ordinary shares. F3 · balance_after: The number of securities underlying each option and the exercise price therefore are represented in ordinary shares. Read SEC document |
| June 05, 2019 Filed Jun 7, 2019 20:13 UTC | BeOne Medicines Ltd. BGNE · Entity 2168 | GrantOrdinary Shares | 433,472 | $0.00 | $0.00 |
DisclosureSEC source: 0001651308-19-000057 · wf-form4_155993838897104.xml · nonDerivative · entry 1 Wu Xiaobin · CIK 0001739452 · President & GM China 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,505,956 F1 · security: Represents securities underlying restricted share units. 1/4th of the securities will vest on each anniversary of June 5, 2019, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events following a change in control. Read SEC document |
| May 01, 2019 Filed May 2, 2019 20:08 UTC | BeOne Medicines Ltd. BGNE · Entity 2168 | SaleAmerican Depositary Shares | 113 | $125.55 | $14,187.07 |
DisclosureSEC source: 0001651308-19-000037 · wf-form4_155682771482970.xml · nonDerivative · entry 4 Wu Xiaobin · CIK 0001739452 · President & GM China 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,365 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $125.39 to $125.57, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depository Shares, sold at each separate price. Read SEC document |
| May 01, 2019 Filed May 2, 2019 20:08 UTC | BeOne Medicines Ltd. BGNE · Entity 2168 | SaleAmerican Depositary Shares | 5,657 | $124.47 | $704,153.38 |
DisclosureSEC source: 0001651308-19-000037 · wf-form4_155682771482970.xml · nonDerivative · entry 3 Wu Xiaobin · CIK 0001739452 · President & GM China 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,478 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $124.19 to $125.04, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depository Shares, sold at each separate price. Read SEC document |
| May 01, 2019 Filed May 2, 2019 20:08 UTC | BeOne Medicines Ltd. BGNE · Entity 2168 | SaleAmerican Depositary Shares | 185 | $125.43 | $23,205.18 |
DisclosureSEC source: 0001651308-19-000037 · wf-form4_155682771482970.xml · nonDerivative · entry 2 Wu Xiaobin · CIK 0001739452 · President & GM China 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,135 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. Read SEC document |
| April 30, 2018 Filed May 3, 2018 00:52 UTC | BeOne Medicines Ltd. BGNE · Entity 2168 | GrantShare Option (Right to Buy) · Derivative | 766,599 | $0.00 Strike: $13.05 | $0.00 |
DisclosureSEC source: 0001104659-18-029973 · a4.xml · derivative · entry 4 Wu Xiaobin · CIK 0001739452 · President & GM China 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 766,599 Underlying: Ordinary Shares · 766,599 shares Expires 2028-04-29 F3 · derivative.exercise_price: The number of securities underlying each option and the exercise price therefore are represented in ordinary shares. The exercise price is equal to 1/13 of the closing price of our ADSs on the date of grant, as each ADS represents 13 ordinary shares. F3 · shares: The number of securities underlying each option and the exercise price therefore are represented in ordinary shares. The exercise price is equal to 1/13 of the closing price of our ADSs on the date of grant, as each ADS represents 13 ordinary shares. F4 · derivative.exercise_date: These securities vest over a five-year period as follows: 20% on April 30, 2019, and the remaining in 48 successive equal monthly installments, subject to continued service. Unvested shares are subject to accelerated vesting upon a change in control or certain termination events. F3 · derivative.underlying_shares: The number of securities underlying each option and the exercise price therefore are represented in ordinary shares. The exercise price is equal to 1/13 of the closing price of our ADSs on the date of grant, as each ADS represents 13 ordinary shares. F3 · balance_after: The number of securities underlying each option and the exercise price therefore are represented in ordinary shares. The exercise price is equal to 1/13 of the closing price of our ADSs on the date of grant, as each ADS represents 13 ordinary shares. Read SEC document |
| April 30, 2018 Filed May 3, 2018 00:52 UTC | BeOne Medicines Ltd. BGNE · Entity 2168 | GrantOrdinary Shares | 1,149,899 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-18-029973 · a4.xml · nonDerivative · entry 1 Wu Xiaobin · CIK 0001739452 · President & GM China 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,149,899 F1 · security: Represents securities underlying restricted share units ("RSUs"). 1/5th of the securities will vest on each anniversary of April 30, 2018, subject to continued service. Unvested securities are subject to accelerated vesting upon a change in control or certain termination events. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.